P. O’Neill

485 total citations
13 papers, 270 citations indexed

About

P. O’Neill is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, P. O’Neill has authored 13 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 3 papers in General Health Professions and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in P. O’Neill's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Pharmaceutical Economics and Policy (7 papers) and Healthcare Policy and Management (4 papers). P. O’Neill is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Pharmaceutical Economics and Policy (7 papers) and Healthcare Policy and Management (4 papers). P. O’Neill collaborates with scholars based in United Kingdom, Spain and United States. P. O’Neill's co-authors include Nancy Devlin, Helen Dakin, Nigel Rice, David Parkin, Yan Feng, Jorge Mestre-Ferrándiz, Martina Garau, F. Maignen, Bernarda Zamora and Jon Sussex and has published in prestigious journals such as Health Economics, Orphanet Journal of Rare Diseases and PharmacoEconomics.

In The Last Decade

P. O’Neill

12 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. O’Neill United Kingdom	6	216	81	37	16	13	13	270
Shiwei Gong China	8	113 0.5×	46 0.6×	26 0.7×	5 0.3×	15 1.2×	17	256
Donato Bonifazi Italy	10	71 0.3×	37 0.5×	156 4.2×	13 0.8×	11 0.8×	24	299
Ott Laius Estonia	7	292 1.4×	29 0.4×	86 2.3×	12 0.8×	11 0.8×	23	396
László Lorenzovici Romania	9	68 0.3×	23 0.3×	14 0.4×	3 0.2×	4 0.3×	22	151
Klaus Rose United States	10	56 0.3×	48 0.6×	195 5.3×	2 0.1×	4 0.3×	45	253
Kevin Houck United States	9	184 0.9×	70 0.9×	22 0.6×		11 0.8×	14	275
Michael J. Gonyeau United States	11	37 0.2×	86 1.1×	39 1.1×	3 0.2×	42 3.2×	28	343
Jiuhong Wu China	7	110 0.5×	51 0.6×	6 0.2×	1 0.1×	6 0.5×	12	192
Olivia Ernstsson Sweden	7	115 0.5×	57 0.7×	11 0.3×		12 0.9×	11	280
Soumendu Sen India	9	32 0.1×	35 0.4×	34 0.9×	3 0.2×	12 0.9×	13	140

Countries citing papers authored by P. O’Neill

Since Specialization

Citations

This map shows the geographic impact of P. O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. O’Neill more than expected).

Fields of papers citing papers by P. O’Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. O’Neill. The network helps show where P. O’Neill may publish in the future.

Co-authorship network of co-authors of P. O’Neill

This figure shows the co-authorship network connecting the top 25 collaborators of P. O’Neill. A scholar is included among the top collaborators of P. O’Neill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. O’Neill. P. O’Neill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

O’Neill, P., et al.. (2021). PP106 Twenty Years Of Orphan Medicines Regulation: Have Treatments Reached Patients In Need Across Europe And Canada?. International Journal of Technology Assessment in Health Care. 37(S1). 19–19.

Serra‐Sastre, Victoria, Simona Bianchi, Jorge Mestre-Ferrándiz, & P. O’Neill. (2020). Does NICE influence the adoption and uptake of generics in the UK?. The European Journal of Health Economics. 22(2). 229–242. 2 indexed citations

Zamora, Bernarda, F. Maignen, P. O’Neill, Jorge Mestre-Ferrándiz, & Martina Garau. (2019). Comparing access to orphan medicinal products in Europe. Orphanet Journal of Rare Diseases. 14(1). 95–95. 66 indexed citations

Zamora, Bernarda, Martina Garau, F. Maignen, P. O’Neill, & Jorge Mestre-Ferrándiz. (2017). OP138 Access To Orphan Drugs In The United Kingdom And Other European Countries. International Journal of Technology Assessment in Health Care. 33(S1). 64–65. 5 indexed citations

Dakin, Helen, Nancy Devlin, Yan Feng, et al.. (2014). The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions. Health Economics. 24(10). 1256–1271. 162 indexed citations

O’Neill, P., et al.. (2014). Projecting Expenditure on Medicines in the NHS (Second Edition). SSRN Electronic Journal. 1 indexed citations

O’Neill, P., et al.. (2013). Projecting Expenditure on Medicines in the UK NHS. PharmacoEconomics. 31(10). 933–957. 5 indexed citations

O’Neill, P., et al.. (2013). Projecting Expenditure on Medicines in the NHS. SSRN Electronic Journal. 1 indexed citations

Dakin, Helen, Nancy Devlin, Yan Feng, et al.. (2013). The Influence of Cost-Effectiveness and Other Factors on NICE Decisions. SSRN Electronic Journal. 6 indexed citations

10.

O’Neill, P., et al.. (2011). The benefits from increased transport research capacity in low-income countries. 1 indexed citations

11.

O’Neill, P. & Nancy Devlin. (2010). An Analysis of NICEʼs ‘Restricted’ (or ‘Optimized’) Decisions. PharmacoEconomics. 28(11). 987–993. 18 indexed citations

12.

O’Neill, P., et al.. (2010). The benefits from increased transport research capacity in developing countries. 1 indexed citations

13.

O’Neill, P., et al.. (1979). Prevalence of compound analgesic in Newcastle (NSW).. PubMed. 8(7). 777–82. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact